A single lot of 75-mg clopidogrel tablets that was distributed nationwide is being recalled by the manufacturer due to mislabeling. International Laboratories, LLC voluntarily initiated the recall ...
Clopidogrel (Zogrell A) is an anti-platelet agent, that is, a drug that inhibits the ability of platelets to clump together as part of a blood clot. Clopidogrel (Zogrell A) is prescribed either alone ...
LONDON, UK – The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) is recommending the approval of a combination tablet that includes clopidogrel and aspirin ...
Bridgewater/Princeton, NJ-The US FDA has approved a new 300-mg tablet of clopidogrel (Plavix, Sanofi-Aventis/Bristol-Myers Squibb) for use as a loading dose in acute ...
A generic version of the standard antiplatelet agent clopidogrel used in Italy may do a worse job of suppressing platelet reactivity than the brand-name form of the drug, according to lab data from an ...
Dual-antiplatelet therapy with aspirin and a thienopyridine is a cornerstone of treatment to prevent thrombotic complications of acute coronary syndromes and percutaneous coronary intervention. To ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results